Literature DB >> 23010797

Altered feeding and body weight following melanocortin administration to the ventral tegmental area in adult rats.

Aaron G Roseberry1.   

Abstract

RATIONALE: The melanocortin system is an important component of the brain circuitry controlling feeding and body weight, and most of the effects of melanocortins are attributed to their actions in hypothalamic and brainstem nuclei. The mesolimbic dopamine system is another component of the central circuitry controlling feeding, and there is evidence that melanocortins can act on mesolimbic dopamine pathways. It is unknown, however, whether melanocortins can act on the mesolimbic dopamine system to regulate feeding.
OBJECTIVE: These studies tested whether injection of melanocortin receptor agonists and antagonists directly into the ventral tegmental area (VTA) of adult rats affects feeding and body weight.
METHODS: Varying doses of the melanocortin receptor agonist, MTII, or the melanocortin receptor antagonist, SHU9119, were injected directly into the VTA, and food intake was measured at specific intervals. In addition, melanocortin receptors in the VTA were chronically blocked through repeated daily injections of SHU9119 into the VTA, and the resulting effects on food intake and body weight were determined.
RESULTS: Injection of MTII into the VTA dose-dependently inhibited feeding for up to 24 h, while injection of SHU9119 into the VTA dose-dependently stimulated feeding for up to 24 h. In addition, chronic blockade of melanocortin receptors in the VTA increased feeding, body weight, and caloric efficiency.
CONCLUSIONS: These studies demonstrate that melanocortins can control feeding and body weight by acting in the VTA and suggest that endogenous melanocortins control feeding in part through actions on the mesolimbic dopamine system in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010797     DOI: 10.1007/s00213-012-2879-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  56 in total

1.  Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments.

Authors:  V Bassareo; G Di Chiara
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

2.  Disruption of brain stimulation-induced feeding by dopamine receptor blockade.

Authors:  A G Phillips; R S Nikaido
Journal:  Nature       Date:  1975-12-25       Impact factor: 49.962

3.  A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity.

Authors:  Yung-Seng Lee; Larry Kok-Seng Poh; Kah-Yin Loke
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

4.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse.

Authors:  A A Butler; R A Kesterson; K Khong; M J Cullen; M A Pelleymounter; J Dekoning; M Baetscher; R D Cone
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

5.  Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area.

Authors:  C F Elias; C Aschkenasi; C Lee; J Kelly; R S Ahima; C Bjorbaek; J S Flier; C B Saper; J K Elmquist
Journal:  Neuron       Date:  1999-08       Impact factor: 17.173

6.  Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections.

Authors:  Huiyuan Zheng; Laurel M Patterson; Curtis B Phifer; Hans-Rudolf Berthoud
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-03-03       Impact factor: 3.619

7.  Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight.

Authors:  H J Grill; A B Ginsberg; R J Seeley; J M Kaplan
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

8.  Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin.

Authors:  Ute Krügel; Thomas Schraft; Holger Kittner; Wieland Kiess; Peter Illes
Journal:  Eur J Pharmacol       Date:  2003-12-15       Impact factor: 4.432

9.  Energy intake and energy expenditure among children with polymorphisms of the melanocortin-3 receptor.

Authors:  David M Savastano; Marian Tanofsky-Kraff; Joan C Han; Cong Ning; Rachael A Sorg; Caroline A Roza; Laura E Wolkoff; Kavitha Anandalingam; Kyra S Jefferson-George; Roberto E Figueroa; Ethan L Sanford; Sheila Brady; Merel Kozlosky; Dale A Schoeller; Jack A Yanovski
Journal:  Am J Clin Nutr       Date:  2009-08-05       Impact factor: 7.045

10.  Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food.

Authors:  R A Wise; J Spindler; H deWit; G J Gerberg
Journal:  Science       Date:  1978-07-21       Impact factor: 47.728

View more
  16 in total

1.  Cross interaction of melanocortinergic and dopaminergic systems in neural modulation.

Authors:  Zhi-Gang He; Bao-Wen Liu; Hong-Bing Xiang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-13

2.  MC4R expression in pedunculopontine nucleus involved in the modulation of midbrain dopamine system.

Authors:  Yan Hao; Xue-Bi Tian; Tao-Tao Liu; Cheng Liu; Hong-Bing Xiang; Jian-Guo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Decreased consumption of rewarding sucrose solutions after injection of melanocortins into the ventral tegmental area of rats.

Authors:  Haw-Han Yen; Aaron G Roseberry
Journal:  Psychopharmacology (Berl)       Date:  2014-07-03       Impact factor: 4.530

4.  Nasal administration of leptin dose-dependently increases dopamine and serotonin outflow in the rat nucleus accumbens.

Authors:  Sonya Neto; Ramya Varatharajan; Kevin Joseph; Andreas Moser
Journal:  J Neural Transm (Vienna)       Date:  2016-07-13       Impact factor: 3.575

5.  Gender-specific roles for the melanocortin-3 receptor in the regulation of the mesolimbic dopamine system in mice.

Authors:  Rachel N Lippert; Kate L J Ellacott; Roger D Cone
Journal:  Endocrinology       Date:  2014-02-26       Impact factor: 4.736

Review 6.  The melanocortin pathway and control of appetite-progress and therapeutic implications.

Authors:  Giulia Baldini; Kevin D Phelan
Journal:  J Endocrinol       Date:  2019-04-01       Impact factor: 4.286

7.  Altered sucrose self-administration following injection of melanocortin receptor agonists and antagonists into the ventral tegmental area.

Authors:  Laranci Shanmugarajah; Anna I Dunigan; Kyle J Frantz; Aaron G Roseberry
Journal:  Psychopharmacology (Berl)       Date:  2017-02-27       Impact factor: 4.530

8.  Alpha-melanocyte stimulating hormone increases the activity of melanocortin-3 receptor-expressing neurons in the ventral tegmental area.

Authors:  Katherine Stuhrman West; Chunxia Lu; David P Olson; Aaron G Roseberry
Journal:  J Physiol       Date:  2019-05-26       Impact factor: 5.182

9.  Pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nucleus of the amygdala induces anxiety via melanocortin receptors.

Authors:  Attilio Iemolo; Mariel Seiglie; Angelo Blasio; Pietro Cottone; Valentina Sabino
Journal:  Psychopharmacology (Berl)       Date:  2016-07-04       Impact factor: 4.530

10.  Melanocortin signaling in the brainstem influences vagal outflow to the stomach.

Authors:  Janell Richardson; Maureen T Cruz; Usnish Majumdar; Amanda Lewin; Kathryn A Kingsbury; Ghazaul Dezfuli; Stefano Vicini; Joseph G Verbalis; Kenneth L Dretchen; Richard A Gillis; Niaz Sahibzada
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.